Dopaminergic Neurons

1. Front Matter

   Pages i-xvii

   PDF

2. The Status Quo and the Future

   • Joseph G. Cannon

   Pages 1-8

3. Structure-Activity Relationships for Benzazepines as D1-Specific Dopamine Antagonists

   • Allen Barnett, Robert McQuade, Richard Chipkin

   Pages 9-15

4. The Development of Potent and Selective D-2 Agonists of the 2-Aminotetralin Group: Their Clinical Applications and their Use in the Isolation of the D-2 Receptor

   • Alan S. Horn, Jan van der Weide, Pieter G. Tepper, Jan B. de Vries, Fokko J. Bosker, Jan Dijk et al.

   Pages 16-21

5. Dopaminergic Ergots

   • R. Markstein, J. M. Vigouret, A. Enz, D. Coward, A. Jaton, U. Briner

   Pages 22-28

6. Autoreceptor Agonists

   • Håkan Wikström

   Pages 29-36

7. Structural Analyses Predict the Primary Pharmacophore and Secondary Sites for the D2 Receptor

   • Philip M. Beart, David T. Manallack

   Pages 37-42

8. Structure-Activity Relationship of Tetrahydroprotoberberines on Central Dopamine Receptors: (−)-Stepholidine—a New Antagonist of Dopamine Receptors

   • G. Z. Jin, K. X. Huang, W. D. Le, S. X. Xu

   Pages 43-45

9. D1 and D2 Dopamine Receptors: Identification by Photoaffinity Labeling and Purification by Affinity Chromatography

   • Marc G. Caron, Susan E. Senogles, Nourdine Amlaiky, Joel G. Berger

   Pages 46-51

10. D2 Dopamine Receptors: Isolation and Mechanism

    • Philip G. Strange

    Pages 52-58

11. Intracellular Ionic Changes Induced by Dopamine Receptor Stimulation in Mammotrophs: Evidence for a K+ Channel-linked Dopamine D-2 Receptor

    • M. Memo, A. Valerio, L. Castelletti, M. Pizzi, C. Missale, M. O. Carruba et al.

    Pages 59-68

12. Dopamine D-2 Receptor Agonists Decrease the Basal Level of Inositol 1,4,5-Trisphosphate in Rat Striatal Slices

    • M. Da Prada, M. Pizzi, A. Valerio, M. Memo, P. F. Spano, W. E. Haefely

    Pages 69-76

13. D₂ Receptor Activation Increases Potassium Conductance in Substantia Nigra Zona Compacta Neurones in vitro

    • M. G. Lacey, N. B. Mercuri, R. A. North

    Pages 77-83

14. Different States of the Dopamine D1 Receptor: Fact or Fantasy?

    • Peter H. Andersen, Mogens Nielsen, Claus Braestrup

    Pages 84-91

15. Purification of Receptors Binding Antipsychotics: Comparison with D2-Dopamine Receptor

    • Y. Nishizawa, M. Sato, S. Hayashi, Y. Takahashi

    Pages 92-95

16. Electrophysiological Investigation of D-1/D-2 Receptor Interactions in the Substantia Nigra and Basal Ganglia

    • J. R. Walters, D. A. Bergstrom, J. H. Carlson, B. G. Weick, H. S. Pan

    Pages 96-102

17. Biochemical Insights into the D-1/D-2 Receptor Interactions

    • J. C. Stoof

    Pages 103-109

18. Dopamine D-1 and D-2 Receptor Differentiation Revealed by Behavioural Studies in Rats

    • Jørn Arnt, Klaus Peter Bøgesø, John Hyttel

    Pages 110-116

19. New Selective D-1 and D-2 Dopamine Receptor Agonists as Further Probes for Behavioural Interactions between D-1 and D-2 Systems

    • John L. Waddington, Angela M. Murray, Kathy M. O’Boyle

    Pages 117-123

20. Neurobiology of Supersensitive D1 and D2-Dopamine Receptors after 6-Hydroxydopamine Lesions

    • George R. Breese, Hugh E. Criswell, Gary E. Duncan, Thomas J. McCown, Robert A. Mueller

    Pages 124-130

The proceedings of the 1987 IUPHAR symposium held in Sydney, Australia are fully documented. Over 100 scientists from 16 countries attended the three-day conference, during which time 68 multi-disciplinary presentations concerning dopamine systems and their regulation were made.

• chromatography
• cocaine
• dopamine
• research

• Clinical Pharmacology and Therapeutics Unit, Austin Hospital, University of Melbourne, Heidelberg, Australia

  P. M. Beart

• Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Harlow, UK

  G. N. Woodruff

• Department of Pharmacology, University of Sydney, Australia

  D. M. Jackson

Policies and ethics